The functional impact of G protein-coupled receptor 142 (Gpr142) on pancreatic β-cell in rodent
Open Access
- 15 February 2019
- journal article
- research article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 471 (4) , 633-645
Abstract
We have recently shown that the G protein-coupled receptor 142 (GPR142) is expressed in both rodent and human pancreatic β-cells. Herein, we investigated the cellular distribution of GPR142 within islets and the effects of selective agonists of GPR142 on glucose-stimulated insulin secretion (GSIS) in the mouse islets and INS-1832/13 cells. Double-immunostaining revealed that GPR142 immunoreactivity in islets mainly occurs in insulin-positive cells. Potentiation of GSIS by GPR142 activation was accompanied by increased cAMP content in INS-1832/13 cells. PKA/Epac inhibition markedly suppressed the effect of GPR142 activation on insulin release. Gpr142 knockdown (Gpr142-KD) in islets was accompanied by elevated release of MCP-1, IFNγ, and TNFα during culture period and abolished the modulatory effect of GPR142 activation on the GSIS. Gpr142-KD had no effect on Ffar1, Ffar2, or Ffar3 mRNA while reducing Gpr56 and increasing Tlr5 and Tlr7 mRNA expression. Gpr142-KD was associated with an increased expression of Chrebp, Txnip, RhoA, and mitochondrial Vdac1 concomitant with a reduced Pdx1, Pax6, and mitochondrial Vdac2 mRNA levels. Long-term exposure of INS-1832/13 cells to hyperglycemia reduced Gpr142 and Vdac2 while increased Chrebp, Txnip, and Vdac1 mRNA expression. GPR142 agonists or Bt2-cAMP counteracted this effect. Glucotoxicity-induced decrease of cell viability in Gpr142-KD INS-1 cells was not affected by GPR142-agonists while Bt2-cAMP prevented it. The results show the importance of Gpr142 in the maintenance of pancreatic β-cell function in rodents and that GPR142 agonists potentiate GSIS by an action, which most likely is due to increased cellular generation of second messenger molecule cAMP.Keywords
Funding Information
- Mats Paulsson Foundation (2017-1)
- Forget foundation (2018-1)
- Diabetes & Wellness foundation
This publication has 40 references indexed in Scilit:
- Pancreatic β‐cell dysfunction, expression of iNOS and the effect of phosphodiesterase inhibitors in human pancreatic islets of type 2 diabetesDiabetes, Obesity and Metabolism, 2012
- Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicityDiabetologia, 2012
- Glucose activation of islets of Langerhans up-regulates Toll-like receptor 5: possible mechanism of protectionClinical and Experimental Immunology, 2011
- VDAC, a multi-functional mitochondrial protein regulating cell life and deathMolecular Aspects of Medicine, 2010
- Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139SLAS Discovery, 2009
- Excessive Islet NO Generation in Type 2 Diabetic GK Rats Coincides with Abnormal Hormone Secretion and Is Counteracted by GLP-1PLOS ONE, 2008
- Glial inhibition of CNS axon regenerationNature Reviews Neuroscience, 2006
- Free fatty acid receptor 1 (FFA1R/GPR40) and its involvement in fatty-acid-stimulated insulin secretionCell and tissue research, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro‐insular axis in miceThe Journal of Physiology, 1999